PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
06-Oct-2022 Immutep announces abstracts accepted for presentation at the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting Immutep
06-Oct-2022 T-CURX GmbH, a German CAR-T Cell Biotech Spin-Off from University of Würzburg, Appoints Ulf Grawunder as CEO B3C newswire
06-Oct-2022 Amphista Therapeutics partners with Domainex to advance portfolio of drug discovery projects targeting protein degradation Sciad Newswire
06-Oct-2022 Medtronic wins U.S. Department of Veterans Affairs contract to provide GI Genius™ intelligent endoscopy module for artificial intelligence (AI) assisted colon cancer screening Cosmo Pharmaceuticals N.V.
06-Oct-2022 Evolva business update: Continued good business momentum Evolva Holding SA
06-Oct-2022 Relief Announces Exclusive Distributor for PKU GOLIKE in the U.S. Relief Therapeutics Holding SA
05-Oct-2022 Medacta announces the first MySpine Anchor procedure completed in the US Medacta Group SA
05-Oct-2022 BioXcel Therapeutics to Host IGALMI™ Commercial Day on October 18, 2022 BioXcel Therapeutics
05-Oct-2022 OGT launches SureSeq Myeloid Plus panel and Universal NGS Complete Workflow OGT
05-Oct-2022 Positive WHO data received for VISITECT® CD4 test OMEGA DIAGNOSTICS
05-Oct-2022 ALTURiX Acquires UK Rights to Desmopressin Oral Solution ALTURiX
04-Oct-2022 atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day atai Life Sciences
04-Oct-2022 Heidelberg Pharma AG Announces Adjustment of Guidance Heidelberg Pharma AG
04-Oct-2022 Shionogi and the Medicines Patent Pool (MPP) sign licence agreement for COVID-19 oral antiviral treatment candidate to increase access in low- and middle-income countries Shionogi
04-Oct-2022 MHRA approves treatment that helps ADHD children and adolescents who experience sleep onset insomnia Colonis
04-Oct-2022 Incyte Announces Agreement to Acquire Medicxi-backed Villaris Therapeutics and Auremolimab (VM6), an Anti-IL-15Rβ Monoclonal Antibody Incyte
04-Oct-2022 Santhera Submits Marketing Authorization Application to the European Medicines Agency for Vamorolone in Duchenne Muscular Dystrophy Santhera
04-Oct-2022 Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH) MPH Health Care AG
04-Oct-2022 Cellusion and Minaris Regenerative Medicine, a Member of Showa Denko Materials, Enter into Business Alliance for the Manufacturing of CLS001 for a Corneal Endothelial Cell Regenerative Therapy B3C newswire
04-Oct-2022 Cosmo and InfectoPharm Announce Signing of License and Distribution Agreement for Winlevi® in Germany, Italy and Austria Cosmo Pharmaceuticals N.V.